![Chris Cline](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Cline
Director of Finance/CFO at TRAVERE THERAPEUTICS, INC.
Net worth: 582 379 $ as of 2024-06-29
Profile
Chris Cline is currently a Member at the National Investor Relations Institute.
He is also currently serving as the Chief Financial Officer at Travere Therapeutics, Inc. since 2014.
Mr. Cline completed his undergraduate degree at Williams College of Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-10 | 70,849 ( 0.09% ) | 582 379 $ | 2024-06-29 |
Chris Cline active positions
Companies | Position | Start |
---|---|---|
TRAVERE THERAPEUTICS, INC. | Director of Finance/CFO | 2022-08-30 |
National Investor Relations Institute
![]() National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Former positions of Chris Cline
Companies | Position | End |
---|---|---|
Elan Corp. Plc
![]() Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 2014-01-31 |
Phase Forward, Inc.
![]() Phase Forward, Inc. Packaged SoftwareTechnology Services Phase Forward, Inc. developed e-process software solutions for accelerating global pharmaceutical development. The company was founded by Paul A. Bleicher and Augustine in 1997 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Training of Chris Cline
Williams College of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
National Investor Relations Institute
![]() National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Elan Corp. Plc
![]() Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Phase Forward, Inc.
![]() Phase Forward, Inc. Packaged SoftwareTechnology Services Phase Forward, Inc. developed e-process software solutions for accelerating global pharmaceutical development. The company was founded by Paul A. Bleicher and Augustine in 1997 and was headquartered in Waltham, MA. | Technology Services |
- Stock Market
- Insiders
- Chris Cline